VistaGen Therapeutics Appoints Nick Tressler as Chief Financial Officer

Reuters
2025.12.01 13:31
portai
I'm PortAI, I can summarize articles.

VistaGen Therapeutics Inc. has appointed Nick Tressler as Chief Financial Officer, effective December 1, 2025. Tressler has over 20 years of financial leadership experience in the life sciences industry.

VistaGen Therapeutics Inc. has appointed Nick Tressler as Chief Financial Officer, effective December 1, 2025. Tressler brings over 20 years of financial leadership experience in the life sciences industry, having previously served as CFO at DYNEX Technologies, American Gene Technologies International, and Senseonics Holdings. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201309124) on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer